Georgia Melenikiotou - Aug 18, 2021 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role: Director
Signature: /s/ Richard Buchholz, Attorney-in-Fact for Georgia Melenikiotou
Stock symbol: INSP
Transactions as of: Aug 18, 2021
Transactions value $: -$126,053
Form type: 4
Date filed: 8/20/2021, 04:05 PM
Previous filing: Jul 13, 2021
Next filing: Aug 24, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INSP	Common Stock	Options Exercise	$79.4K	+852	+304.29%	$93.14	1.13K	Aug 18, 2021	Direct
transaction	INSP	Common Stock	Sale	-$176K	-852	-75.27%	$207.08	280	Aug 18, 2021	Direct	F1
transaction	INSP	Common Stock	Sale	-$29K	-140	-50%	$206.97	140	Aug 19, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INSP	Employee Stock Option (Right to Buy)	Award	$0	-852	-22.22%	$0.00	2.98K	Aug 18, 2021	Common Stock	852	$93.14	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.96 to $207.20. The reporting person undertakes to provide the Company, any security holder of Inspire Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The original 3,834 shares underlying the option have vested or will vest and become exercisable in three equal annual installments that began on July 8, 2021, subject to the Non-Employee Director continuing in service through each applicable vesting date.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.96 to $207.20. The reporting person undertakes to provide the Company, any security holder of Inspire Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The original 3,834 shares underlying the option have vested or will vest and become exercisable in three equal annual installments that began on July 8, 2021, subject to the Non-Employee Director continuing in service through each applicable vesting date.